Literature DB >> 35100182

Relationship of Blood Pressure and White Matter Hyperintensity Burden With Level of and Change in Cognition in Older Black Adults.

Melissa Lamar1, Debra A Fleischman, Sue E Leurgans, Neelum Aggarwal, Lei Yu, Namhee Kim, Victoria Poole, S Duke Han, Konstantinos Arfanakis, Lisa L Barnes.   

Abstract

OBJECTIVE: Elevations in blood pressure (BP) and associated white matter hyperintensities (WMHs) are chronic comorbid conditions among older Black adults. We investigated whether WMHs modify the association between late-life BP and cognition within older Black adults.
METHODS: A total of 167 Black adults (age, ~75 years; without dementia at baseline) participating in neuroimaging studies at the Rush Alzheimer's Disease Center were evaluated for BP markers of cardiovascular health, including systolic BP, diastolic BP, pulse pressure, mean arterial pressure (MAP), and hypertension, and were assessed for global and domain-specific cognition at baseline and annually for up to 8 years. WMHs adjusted for intracranial volume were quantified at baseline.
RESULTS: Models adjusted for relevant confounders and the interaction of these variables with time revealed differential associations between BP markers and baseline cognition; however, only elevated diastolic BP predicted faster cognitive, that is, episodic memory, decline (estimate = -0.002, standard error = 0.0009, p = .002). Although WMH burden did not modify the association between diastolic BP and episodic memory decline, it did interact with diastolic BP to lower episodic memory at baseline (estimate = -0.051, standard error = 0.012, p = .0001); that is, greater WMHs combined with higher diastolic BP resulted in the lowest baseline episodic memory scores. A similar profile was noted for WMHs, MAP, and baseline episodic memory. Hypertension was neither associated with cognition nor modified by WMH burden after multiple comparisons correction.
CONCLUSION: Late-life diastolic BP was associated with faster rates of episodic memory decline in older Black adults; together with higher WMH burden, it (and MAP) lowered the point at which individuals begin their course of decline toward pathological aging.
Copyright © 2022 by the American Psychosomatic Society.

Entities:  

Mesh:

Year:  2022        PMID: 35100182      PMCID: PMC9064910          DOI: 10.1097/PSY.0000000000001059

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   3.864


  39 in total

1.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study.

Authors:  H Petrovitch; L R White; G Izmirilian; G W Ross; R J Havlik; W Markesbery; J Nelson; D G Davis; J Hardman; D J Foley; L J Launer
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Blood pressure and cognition among older adults: a meta-analysis.

Authors:  Katherine A Gifford; Maria Badaracco; Dandan Liu; Yorghos Tripodis; Amanda Gentile; Zengqi Lu; Joseph Palmisano; Angela L Jefferson
Journal:  Arch Clin Neuropsychol       Date:  2013-07-09       Impact factor: 2.813

3.  Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: A population-based cohort study.

Authors:  Anna Marseglia; Laura Fratiglioni; Grégoria Kalpouzos; Rui Wang; Lars Bäckman; Weili Xu
Journal:  Alzheimers Dement       Date:  2018-08-13       Impact factor: 21.566

4.  White matter predictors of cognitive functioning in older adults.

Authors:  Irene B Meier; Jennifer J Manly; Frank A Provenzano; Karmen S Louie; Ben T Wasserman; Erica Y Griffith; Josina T Hector; Elizabeth Allocco; Adam M Brickman
Journal:  J Int Neuropsychol Soc       Date:  2012-03-06       Impact factor: 2.892

5.  Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study.

Authors:  David A Bennett; Julie A Schneider; Neelum T Aggarwal; Zoe Arvanitakis; Raj C Shah; Jeremiah F Kelly; Jacob H Fox; Elizabeth J Cochran; Danielle Arends; Anna D Treinkman; Robert S Wilson
Journal:  Neuroepidemiology       Date:  2006-10-10       Impact factor: 3.282

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 7.  The relationship between obesity and cognitive health and decline.

Authors:  Louise Dye; Neil Bernard Boyle; Claire Champ; Clare Lawton
Journal:  Proc Nutr Soc       Date:  2017-09-11       Impact factor: 6.297

Review 8.  Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future.

Authors:  Timothy M Hughes; Kaycee M Sink
Journal:  Am J Hypertens       Date:  2015-11-11       Impact factor: 2.689

9.  Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.

Authors:  Agustín Ruiz; Pedro Pesini; Ana Espinosa; Virginia Pérez-Grijalba; Sergi Valero; Oscar Sotolongo-Grau; Montserrat Alegret; Inmaculada Monleón; Asunción Lafuente; Mar Buendía; Marta Ibarria; Susana Ruiz; Isabel Hernández; Itziar San José; Lluís Tárraga; Mercè Boada; Manuel Sarasa
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

10.  BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities.

Authors:  Ludovica Griffanti; Giovanna Zamboni; Aamira Khan; Linxin Li; Guendalina Bonifacio; Vaanathi Sundaresan; Ursula G Schulz; Wilhelm Kuker; Marco Battaglini; Peter M Rothwell; Mark Jenkinson
Journal:  Neuroimage       Date:  2016-07-09       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.